Atmospheric microbiological testing is the systematic sampling and analysis of airborne microorganisms—including bacteria, fungi, and microbial by-products—in indoor air, cleanrooms, healthcare facilities, and process environments. By quantifying viable bioaerosols against recognized standards such as ISO 16000, ISO 14698, and GB/T 18883, organizations can verify air hygiene, control infection and contamination risks, and demonstrate regulatory compliance. This technical guide explains the sampling principles, tested sample types, target organisms, analytical methods, acceptance criteria, and typical applications of airborne microbiological monitoring.
Technical Overview
Atmospheric microbiological testing, also referred to as airborne microbiological monitoring or bioaerosol testing, is the process of collecting, culturing, enumerating, and identifying microorganisms suspended in air. Airborne microbes exist as bioaerosols—particles of biological origin such as bacterial cells, fungal spores, yeast cells, actinomycete fragments, pollen, and microbial debris—that can remain viable and travel significant distances on air currents.
The microbial flora of air is dominated by Gram-positive spore-forming bacilli, staphylococci and micrococci, and mold genera such as Cladosporium, Penicillium, Aspergillus, and Alternaria. Common sources include soil dust, water aerosols, human and animal activity, vegetation, and contaminated HVAC systems. Inhalation of elevated concentrations of these organisms is associated with allergic sensitization, asthma exacerbation, opportunistic infections such as invasive aspergillosis, and toxic or inflammatory responses triggered by endotoxins and (1→3)-β-D-glucans.
The discipline is governed by an international and national framework of standards, which accredited third-party laboratories apply when designing test protocols and evaluating results:
- ISO 16000-16, -17, and -18 for the detection and enumeration of molds in indoor air by impaction, filtration, and impingement, respectively.
- ISO 14698-1 and ISO 14698-2 for biocontamination control in cleanrooms and associated controlled environments, including data evaluation and interpretation.
- ISO 14644-1 for the associated classification of air cleanliness by particle concentration, which contextualizes microbiological qualification.
- ISO 8573-7 for testing viable microbiological contamination in compressed air and process gases.
- EN 13098 for the measurement of airborne microorganisms and microbial compounds in workplace atmospheres.
- GB/T 18883-2022 for indoor air quality, including total bacterial count limits; GB 15982-2012 for hospital disinfection hygiene; and GB 50333-2013 for hospital clean operating department construction.
Results are expressed primarily as colony forming units per cubic meter of air (CFU/m³) for active volumetric methods, or as CFU per plate per exposure period for passive settle plate methods, frequently supplemented by genus- or species-level identification.
Testing Samples
Indoor and Ambient Air
Air from offices, residences, schools, hotels, shopping malls, museums, and public transport vehicles is tested to assess general indoor air quality and to investigate occupant complaints, musty odors, dampness, or visible mold growth. Outdoor (ambient) reference samples are typically collected in parallel to distinguish indoor amplification from background levels.
Cleanroom and Controlled-Environment Air
Air from pharmaceutical, biotechnology, and medical device cleanrooms—including aseptic filling zones, gowning rooms, and background environments—is monitored as part of GMP environmental monitoring programs. Grade A through Grade D environments each carry defined microbiological action limits, and testing supports initial qualification, routine surveillance, and media fill studies.
Hospital and Healthcare Facility Air
Air from operating theaters, intensive care units, protective isolation wards, hemodialysis rooms, dental suites, and disinfection supply centers is tested against hospital hygienic standards. GB 15982-2012 defines air limits of ≤10 CFU/m³ for Class I environments (e.g., laminar-flow operating rooms), ≤200 CFU/m³ for Class II environments, and ≤500 CFU/m³ for Class III environments, while GB 50333-2013 specifies requirements for ultraclean operating rooms, typically ≤5 CFU/m³.
Compressed Air and Process Gas
Compressed air and gases used in food processing, beverage bottling, pharmaceutical manufacturing, and electronics production are tested per ISO 8573-7, since contaminated compressed air can directly inoculate products, packaging, or product-contact surfaces during blow-off, aeration, and pneumatic conveying operations.
Ventilation System and Specialty Environment Air
This category includes air from HVAC ducts, air handling units, cooling-tower plume zones associated with Legionella aerosol risk, archives and libraries, animal husbandry facilities, composting plants, wastewater treatment plants, and biotechnology fermentation halls, where occupational exposure and process contamination risks must be characterized.
Testing Items
Testing portfolios for atmospheric microbiological analysis typically include the following items, selected according to the environment, applicable standard, and risk assessment:
- Total aerobic bacterial count: enumeration of viable mesophilic bacteria on tryptic soy agar or nutrient agar after incubation at 30–37 °C for 48 hours.
- Total fungal (mold and yeast) count: enumeration on Sabouraud dextrose agar, potato dextrose agar, malt extract agar, or rose bengal chloramphenicol agar after incubation at 25–28 °C for 3 to 7 days.
- Indicator and pathogenic bacteria: Staphylococcus aureus (mannitol salt agar), beta-hemolytic streptococci including Group A Streptococcus (blood agar with bacitracin disks), Pseudomonas aeruginosa (cetrimide agar), and coliform bacteria including Escherichia coli (MacConkey or chromogenic media).
- Target fungi of clinical significance: screening and identification of Aspergillus fumigatus and other opportunistic molds in hospital and immunocompromised-patient settings.
- Microbial cell-wall markers: bacterial endotoxin by the Limulus amebocyte lysate (LAL) assay and (1→3)-β-D-glucan by factor G-based assays, reported in endotoxin units per cubic meter.
- Total (culturable plus non-culturable) microbial burden determined by culture-independent methods such as quantitative PCR or ATP-based assays.
- Species-level identification of isolates using microscopy, biochemical profiling, MALDI-TOF mass spectrometry, and 16S rRNA or ITS region gene sequencing.
Testing Methods
Active Volumetric Sampling by Impaction
Impaction is the most widely used active method. A calibrated pump draws a known volume of air through perforated plates or a slit, accelerating particles onto the surface of a prepared agar plate. Common configurations include single-stage multi-hole impactors, six-stage cascade impactors operating at 28.3 L/min that provide size-resolved profiles, slit-to-agar samplers for time-resolved monitoring, and portable centrifugal and high-flow units operating at 50–100 L/min or more. Multi-hole impactor data are corrected using the positive-hole statistical correction to account for multiple particles striking the same aperture. Sampling volumes are selected to avoid plate overload, generally keeping colony counts below approximately 300 CFU per plate.
Liquid Impingement and Membrane Filtration
Liquid impingers collect bioaerosols into a sterile liquid medium at approximately 12.5 L/min, yielding a suspension suitable for dilution plating onto multiple media, inoculation into enrichment broths, and direct molecular analysis. Gelatin or mixed-cellulose-ester membrane filtration (0.3–0.45 µm pore size) offers high collection efficiency for low-bioburden environments; gelatin membranes can be dissolved in warm buffer before assay, a technique favored for Grade A/B cleanroom monitoring and compressed air testing.
Passive Settle Plate Method
In the passive method, standard 90 mm agar plates are exposed for a defined period—commonly 5 minutes in hospital hygiene surveys or up to 4 hours in cleanroom monitoring—allowing viable particles to settle by gravity. Results are reported as CFU per plate per exposure time. Although the method does not measure true airborne concentration, it correlates with surface contamination risk and remains a standard complement to active sampling under ISO 14698 and hospital hygienic standards.
Incubation, Enumeration, and Calculation
After sampling, plates are inverted and incubated under the conditions appropriate to each medium and target organism, typically 48 hours at 35 ± 1 °C or 30–35 °C for bacteria and 3–7 days at 25–28 °C for fungi. Colonies are counted, and the airborne concentration is calculated as CFU/m³ = (colony count × 1000) ÷ (sampling flow rate in L/min × sampling time in minutes), applying positive-hole or impaction-efficiency corrections where applicable. Reports document sampling locations, instrument model and flow rate, sampling volume, incubation conditions, temperature and relative humidity during sampling, and any deviations.
Quality Assurance and Sampling Design
Representative sampling requires careful point selection, typically at the breathing zone height of 1.2–1.5 m, at least 0.5–1 m from walls and away from supply diffusers, supply and exhaust registers, and direct sunlight. The number of sampling points is determined by room area and function, and duplicate samples, field blanks, and unexposed media controls accompany each campaign. Sampler heads are sterilized between uses, flow rates are verified with a calibrated flow meter, and plates are transported and incubated promptly to preserve viability.
Rapid and Molecular Complementary Methods
Where expedited results or non-culturable organisms are of concern, ATP bioluminescence provides rapid on-site screening, while quantitative PCR, LAMP assays, and immunological methods detect specific organisms and viruses that cannot be reliably cultured. Flow cytometry and next-generation sequencing are increasingly used for comprehensive bioaerosol characterization, although culture-based enumeration remains the reference basis for regulatory acceptance.
Applications
Atmospheric microbiological testing is applied across regulated and non-regulated sectors wherever airborne microorganisms pose a risk to human health, product quality, or process integrity:
- Pharmaceutical and biotechnology manufacturing: routine environmental monitoring of aseptic processing areas, cleanroom qualification and requalification, and investigation of excursions.
- Hospital infection control: commissioning and periodic surveillance of operating theaters and ICU air, verification of laminar-flow and filtration performance, and epidemiological investigation of outbreaks such as surgical-site aspergillosis.
- Food, beverage, and packaging industries: validation of hygienic zoning, monitoring of compressed air contacting products or packaging, and control of fungal contamination in ripening and fermentation rooms.
- Building indoor air quality assessment: response to occupant complaints, dampness and mold investigations per EN 13098 and ISO 16000 guidance, and pre- and post-remediation verification.
- Public venues and transportation: acceptance testing of newly constructed or renovated schools, kindergartens, hotels, and passenger vehicles against GB/T 18883 criteria.
- Occupational and environmental hygiene: exposure assessment at composting facilities, wastewater treatment plants, animal husbandry operations, and waste sorting centers.
- Research and conservation: microbial ecology studies of atmospheric bioaerosols and preventive monitoring of archives, museums, and heritage sites.
FAQ
What is the difference between active and passive air sampling?
Active sampling uses a powered device to draw a measured volume of air onto a collection medium, producing a quantitative result in CFU/m³. Passive settle plates simply expose agar to the air for a set period and report CFU per plate per exposure time; they reflect deposition risk rather than true concentration and are best used as a supplement to active methods.
What are typical acceptance limits for airborne microorganisms?
Limits depend entirely on the environment and governing standard. Under GMP cleanroom grades, action limits range from below 1 CFU/m³ in Grade A aseptic zones to approximately 200 CFU/m³ in Grade D backgrounds. GB 15982-2012 specifies ≤10, ≤200, and ≤500 CFU/m³ for hospital Class I, II, and III environments respectively, while GB/T 18883-2022 sets a total bacterial count limit of 1500 CFU/m³ for indoor air, with pathogenic organisms such as hemolytic streptococci and Staphylococcus aureus required to be absent.
How long does atmospheric microbiological testing take?
Field sampling itself typically takes 5 to 30 minutes per point depending on expected bioburden. Laboratory turnaround is governed by incubation: approximately 2 days for bacterial counts, 3 to 7 days for fungal counts, and several additional days when pathogen isolation or species-level identification by MALDI-TOF mass spectrometry or sequencing is required. A complete report is generally issued within 7 to 10 working days.
Can airborne viruses be tested?
Yes, but by culture-independent methods rather than standard plate culture. Airborne viruses are captured by filtration or liquid impingement and detected using quantitative PCR or other nucleic acid amplification techniques. Such testing is frequently performed by accredited third-party laboratories for outbreak investigation and research purposes, whereas routine regulatory monitoring focuses on bacteria and fungi.
How are sampling locations and frequency determined?
Locations are selected based on a risk assessment covering occupancy, air distribution patterns, and contamination sources, with samples taken at breathing height in occupied zones plus outdoor reference points. Frequency ranges from continuous or per-shift monitoring in Grade A/B cleanrooms, to monthly or quarterly surveillance in hospitals, to annual or event-driven testing in general buildings.
Why do repeated measurements at the same site sometimes differ significantly?
Airborne microbial concentrations are inherently variable and respond to human activity, door and window operation, HVAC running status, cleaning and disinfection schedules, season, and relative humidity. Properly standardized protocols—fixed sampling points, recorded environmental conditions, and consistent operating states—are essential for producing comparable, interpretable trend data over time.